Anxiety and Depression in Patients with Parkinson's Disease
スポンサーリンク
概要
- 論文の詳細を見る
Objective To investigate the prevalence and clinical correlates of anxiety and depression in patients with Parkinson's disease (PD) and to examine the relationship between anxiety and depression and the quality of life (QOL). Methods One hundred and seventeen patients with PD completed the State-Trait Anxiety Inventory (STAI), the Beck Depression Inventory Second Edition (BDI-II), Starkstein's Apathy Scale (AS) and QOL battery. Hoehn and Yahr (HY) staging, the Unified Parkinson's Disease Rating Scale (UPDRS) and the Mini-Mental State Examination (MMSE) were administered on the same day. Results Anxiety (STAI score ≥41 for men or ≥42 for women) was diagnosed in 55% of the patients and depression (BDI-II score ≥14) was diagnosed in 56% of the patients. Anxiety coexisted with depression in 41% of the patients, while depression without anxiety was observed in 15% of the patients and anxiety without depression was observed in 14% of the patients. The STAI score was found to be significantly correlated with the UPDRS (I, IVC) and AS scores, whereas the BDI-II score was found to correlate with the HY stage and the UPDRS (I, III, IVB, C) and AS scores. Both the STAI and BDI-II scores were found to negatively correlate with QOL. A multivariate analysis revealed that depression and anxiety are similarly associated with the PD specific QOL (PDQ-39), while motor severity, as judged by the HY stage and UPDRS III score, is not. Conclusion These findings indicate that recognizing anxiety and depression in patients with PD is important, since both conditions are commonly observed in patients with PD and are similarly associated with the QOL, independent of motor severity.
著者
-
Okuda Bungo
Department Of Neurology Ehime Prefectural Central Hospital
-
Oka Nobuyuki
Department Of Internal Medicine Shimane Medical University
-
YAMANISHI Toshiyuki
Department of Neurology, Kinki University Hospital
-
Tachibana Hisao
Department of General Internal Medicine, Hyogo College of Medicine
-
Oka Nobuyuki
Department of Rehabilitation, NHO South Kyoto Hospital, Japan
-
Toda Kazuo
Toda Internal Medicine-Rehabilitation Clinic, Japan
-
Tachibana Hisao
Department of Internal Medicine, Hyogo College of Medicine, Japan
-
Oguru Miyako
Department of Internal Medicine, Hyogo College of Medicine, Japan
-
Matsui Kiyohiro
Department of Internal Medicine, Hyogo College of Medicine, Japan
-
Yamanishi Toshiyuki
Department of Internal Medicine, Hyogo College of Medicine, Japan
関連論文
- Four mutations of the spastin gene in Japanese families with spastic paraplegia
- Vaccine-associated Paralytic Poliomyelitis Caused by Contact Infection
- Hypoxia-inducible factor 1α may be a marker for vasculitic neuropathy
- Increased cyclooxygenase-2 in inflammatory demyelinating neuropathy
- ISLET CELL ANTIBODIES AND ANTITHYROID ANTIBODIES IN TYPE 1 DIABETICS
- Accumulation of V_α7.2-J_α33 invariant T cells in human autoimmune inflammatory lesions in the nervous system
- Magnetic resonance imaging in neuro-Behcet's disease
- Anterior Cerebral Artery Territory Infarctions Presenting With Ascending Tetraparesis
- Clinical and Pathological Findings in Microscopic Polyangiitis
- Two subtypes of Churg-Strauss syndrome with neuropathy : the roles of eosinophils and ANCA
- Anxiety and Depression in Patients with Parkinson's Disease
- Efficacy of Early Intravenous Immunoglobulin for Eosinophilic Granulomatosis with Polyangiitis with Drastically Progressive Neuropathy: A Synopsis of Two Cases
- Caudato-pallido-nigral degeneration with cerebral atrophy: Report of a case with parkinsonism and dementia.
- MULTIPLE INTRACEREBRAL HEMATOMAS WITHOUT TUMOR: REPORT OF AN UNUSUAL CASE
- Hypertonic glycerol therapy of cerebral edema and its possible side-effects.
- Molecular analysis of the genes causing recessive demyelinating Charcot-Marie-Tooth disease in Japan